Why cancer care delays persist and what payers can do differently
Cancer outcomes have improved but delays and fragmentation still define much of the care journey.
Patients wait an average of 156 days between screening and diagnosis, and every four-week delay can increase mortality risk by 6 to 8 percent.
For health plans, these gaps create clinical risk, rising costs and poor member experiences.
This report explores how health plans are moving toward coordinated, member-centric cancer care models that address the full continuum from early detection through treatment and beyond.
Insights include:
Patients wait an average of 156 days between screening and diagnosis, and every four-week delay can increase mortality risk by 6 to 8 percent.
For health plans, these gaps create clinical risk, rising costs and poor member experiences.
This report explores how health plans are moving toward coordinated, member-centric cancer care models that address the full continuum from early detection through treatment and beyond.
Insights include:
- Where breakdowns occur across the cancer care journey
- How delays in screening, diagnosis and treatment impact outcomes and costs
- Why member trust and engagement are critical to care coordination
Please fill out the form to download the whitepaper.